Ludlow Research Launches Sector Focus on OTC Healthcare Issuers

(NEW YORK)–Ludlow Research, an equity research firm located in New York City, announced upcoming research focus on the small-cap Healthcare and Medical Device sector. Inflation, rising interest rates, falling consumer confidence, stress within banking sector all signal the possibility for a recession if not softer economy in 2023. While no investment is completely recession-proof, healthcare […]

Continue Reading

Q BioMed (QBIO) Issued Bullish Valuation Outlook on Liver Cancer Drug

(NEW YORK)–Ludlow Research issued research alert to its subscribers on Q BioMed Inc. (OTCQB: QBIO), a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, with $0.10+ price target based on current market cap valuation, and potential for its Liver cancer drug patent. On Feb. 10, […]

Continue Reading

MetAlert (MLRT) Analyst Brief

MetAlert, Inc. (OTC: MLRT) is a pioneer in smart, mobile, and wearable tracking and recovery location-based solutions, supported through a proprietary iot enterprise monitoring platform and intellectual property portfolio. The Company offers a global end-to-end solution of hardware, software and connectivity and develops two-way GPS tracking technologies, which seamlessly integrate with consumer products and enterprise […]

Continue Reading

Ehave (EHVVF) Bullish Outlook on Recession and Growing Mental Health Crisis

(NEW YORK)–Ludlow Research initiates research opinion on Ehave, Inc. (OTC: EHVVF), a leading healthcare services and technology company, based on growing risk for mental health crisis and demand for alternative treatment options. BULLISH OUTLOOK IN RECESSION Ehave is a healthcare technology company, which is focused on healthcare data collection, management, and analytics for the mental […]

Continue Reading